Spinal cord multi‐parametric magnetic resonance imaging for survival prediction in amyotrophic lateral sclerosis
Background and purpose Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the assessment of disease severity and several studies also suggest a strong relationship between spinal cord (SC) atrophy described by magnetic r...
Saved in:
Published in | European journal of neurology Vol. 24; no. 8; pp. 1040 - 1046 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
John Wiley & Sons, Inc
01.08.2017
Wiley |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Background and purpose
Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the assessment of disease severity and several studies also suggest a strong relationship between spinal cord (SC) atrophy described by magnetic resonance imaging (MRI) and disease progression. The aim of the study was to determine the predictive added value of multimodal SC MRI on survival.
Methods
Forty‐nine ALS patients were recruited and clinical data were collected. Patients were scored on the Revised ALS Functional Rating Scale and manual muscle testing. They were followed longitudinally to assess survival. The cervical SC was imaged using the 3 T MRI system. Cord volume and cross‐sectional area (CSA) at each vertebral level were computed. Diffusion tensor imaging metrics were measured. Imaging metrics and clinical variables were used as inputs for a multivariate Cox regression survival model.
Results
On building a multivariate Cox regression model with clinical and MRI parameters, fractional anisotropy, magnetization transfer ratio and CSA at C2–C3, C4–C5, C5–C6 and C6–C7 vertebral levels were significant. Moreover, the hazard ratio calculated for CSA at the C3–C4 and C5–C6 levels indicated an increased risk for patients with SC atrophy (respectively 0.66 and 0.68). In our cohort, MRI parameters seem to be more predictive than clinical variables, which had a hazard ratio very close to 1.
Conclusions
It is suggested that multimodal SC MRI could be a useful tool in survival prediction especially if used at the beginning of the disease and when combined with clinical variables. To validate it as a biomarker, confirmation of the results in bigger independent cohorts of patients is warranted. |
---|---|
AbstractList | Background and purpose
Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis (
ALS
). Neuroimaging seems to be promising in the assessment of disease severity and several studies also suggest a strong relationship between spinal cord (
SC
) atrophy described by magnetic resonance imaging (
MRI
) and disease progression. The aim of the study was to determine the predictive added value of multimodal
SC MRI
on survival.
Methods
Forty‐nine
ALS
patients were recruited and clinical data were collected. Patients were scored on the Revised
ALS
Functional Rating Scale and manual muscle testing. They were followed longitudinally to assess survival. The cervical SC was imaged using the 3 T
MRI
system. Cord volume and cross‐sectional area (
CSA
) at each vertebral level were computed. Diffusion tensor imaging metrics were measured. Imaging metrics and clinical variables were used as inputs for a multivariate Cox regression survival model.
Results
On building a multivariate Cox regression model with clinical and
MRI
parameters, fractional anisotropy, magnetization transfer ratio and
CSA
at C2–C3, C4–C5, C5–C6 and C6–C7 vertebral levels were significant. Moreover, the hazard ratio calculated for
CSA
at the C3–C4 and C5–C6 levels indicated an increased risk for patients with
SC
atrophy (respectively 0.66 and 0.68). In our cohort,
MRI
parameters seem to be more predictive than clinical variables, which had a hazard ratio very close to 1.
Conclusions
It is suggested that multimodal
SC MRI
could be a useful tool in survival prediction especially if used at the beginning of the disease and when combined with clinical variables. To validate it as a biomarker, confirmation of the results in bigger independent cohorts of patients is warranted. BACKGROUND AND PURPOSEAssessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the assessment of disease severity and several studies also suggest a strong relationship between spinal cord (SC) atrophy described by magnetic resonance imaging (MRI) and disease progression. The aim of the study was to determine the predictive added value of multimodal SC MRI on survival.METHODSForty-nine ALS patients were recruited and clinical data were collected. Patients were scored on the Revised ALS Functional Rating Scale and manual muscle testing. They were followed longitudinally to assess survival. The cervical SC was imaged using the 3 T MRI system. Cord volume and cross-sectional area (CSA) at each vertebral level were computed. Diffusion tensor imaging metrics were measured. Imaging metrics and clinical variables were used as inputs for a multivariate Cox regression survival model.RESULTSOn building a multivariate Cox regression model with clinical and MRI parameters, fractional anisotropy, magnetization transfer ratio and CSA at C2-C3, C4-C5, C5-C6 and C6-C7 vertebral levels were significant. Moreover, the hazard ratio calculated for CSA at the C3-C4 and C5-C6 levels indicated an increased risk for patients with SC atrophy (respectively 0.66 and 0.68). In our cohort, MRI parameters seem to be more predictive than clinical variables, which had a hazard ratio very close to 1.CONCLUSIONSIt is suggested that multimodal SC MRI could be a useful tool in survival prediction especially if used at the beginning of the disease and when combined with clinical variables. To validate it as a biomarker, confirmation of the results in bigger independent cohorts of patients is warranted. Background and purpose Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the assessment of disease severity and several studies also suggest a strong relationship between spinal cord (SC) atrophy described by magnetic resonance imaging (MRI) and disease progression. The aim of the study was to determine the predictive added value of multimodal SC MRI on survival. Methods Forty‐nine ALS patients were recruited and clinical data were collected. Patients were scored on the Revised ALS Functional Rating Scale and manual muscle testing. They were followed longitudinally to assess survival. The cervical SC was imaged using the 3 T MRI system. Cord volume and cross‐sectional area (CSA) at each vertebral level were computed. Diffusion tensor imaging metrics were measured. Imaging metrics and clinical variables were used as inputs for a multivariate Cox regression survival model. Results On building a multivariate Cox regression model with clinical and MRI parameters, fractional anisotropy, magnetization transfer ratio and CSA at C2–C3, C4–C5, C5–C6 and C6–C7 vertebral levels were significant. Moreover, the hazard ratio calculated for CSA at the C3–C4 and C5–C6 levels indicated an increased risk for patients with SC atrophy (respectively 0.66 and 0.68). In our cohort, MRI parameters seem to be more predictive than clinical variables, which had a hazard ratio very close to 1. Conclusions It is suggested that multimodal SC MRI could be a useful tool in survival prediction especially if used at the beginning of the disease and when combined with clinical variables. To validate it as a biomarker, confirmation of the results in bigger independent cohorts of patients is warranted. Background: Assessing survival is a critical issue in patients with Amyotrophic Lateral Sclerosis (ALS). Neuroimaging seems to be promising in the assessment of disease severity and several studies also suggest a strong relationship between spinal cord (SC) atrophy described by MRI and disease progression.Aim of the study was than to determine the predictive added value of multimodal SC MRI on survival.Methods: 49 ALS patients were recruited and clinical data collected. Patients were scored on ALSFRS-R and manual muscle testing. They were followed longitudinally to assess survival. Cervical spinal cord was imaged using 3T MRI system. Cord volume and cross-sectional area (CSA) at each vertebral level were computed. DTI metrics were measured. Imaging metrics and clinical variables were used as inputs for a multivariate Cox regression survival model.Results: When building a multivariate Cox regression model with clinical and MRI parameters, FA, MTR, and CSA at C2-C3, C4-C5, C5-C6 and C6-C7 vertebral levels were significant. Moreover, hazard ratio (HR) calculated for CSA at C3-C4 and C5-C6 levels indicated an increased risk for patients with SC atrophy (respectively 0.66 and 0.68). In our cohort, MRI parameters seem to be more predictive than clinical variables, which had HR very close to 1.Conclusions: We suggest that multimodal SC MRI could be a useful tool in survival prediction especially if used at the beginning of the disease and when combined with clinical variables. To validate it as a biomarker, results confirmation in independent bigger cohorts of patients is warranted. Background and purpose Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the assessment of disease severity and several studies also suggest a strong relationship between spinal cord (SC) atrophy described by magnetic resonance imaging (MRI) and disease progression. The aim of the study was to determine the predictive added value of multimodal SC MRI on survival. Methods Forty-nine ALS patients were recruited and clinical data were collected. Patients were scored on the Revised ALS Functional Rating Scale and manual muscle testing. They were followed longitudinally to assess survival. The cervical SC was imaged using the 3 T MRI system. Cord volume and cross-sectional area (CSA) at each vertebral level were computed. Diffusion tensor imaging metrics were measured. Imaging metrics and clinical variables were used as inputs for a multivariate Cox regression survival model. Results On building a multivariate Cox regression model with clinical and MRI parameters, fractional anisotropy, magnetization transfer ratio and CSA at C2-C3, C4-C5, C5-C6 and C6-C7 vertebral levels were significant. Moreover, the hazard ratio calculated for CSA at the C3-C4 and C5-C6 levels indicated an increased risk for patients with SC atrophy (respectively 0.66 and 0.68). In our cohort, MRI parameters seem to be more predictive than clinical variables, which had a hazard ratio very close to 1. Conclusions It is suggested that multimodal SC MRI could be a useful tool in survival prediction especially if used at the beginning of the disease and when combined with clinical variables. To validate it as a biomarker, confirmation of the results in bigger independent cohorts of patients is warranted. Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the assessment of disease severity and several studies also suggest a strong relationship between spinal cord (SC) atrophy described by magnetic resonance imaging (MRI) and disease progression. The aim of the study was to determine the predictive added value of multimodal SC MRI on survival. Forty-nine ALS patients were recruited and clinical data were collected. Patients were scored on the Revised ALS Functional Rating Scale and manual muscle testing. They were followed longitudinally to assess survival. The cervical SC was imaged using the 3 T MRI system. Cord volume and cross-sectional area (CSA) at each vertebral level were computed. Diffusion tensor imaging metrics were measured. Imaging metrics and clinical variables were used as inputs for a multivariate Cox regression survival model. On building a multivariate Cox regression model with clinical and MRI parameters, fractional anisotropy, magnetization transfer ratio and CSA at C2-C3, C4-C5, C5-C6 and C6-C7 vertebral levels were significant. Moreover, the hazard ratio calculated for CSA at the C3-C4 and C5-C6 levels indicated an increased risk for patients with SC atrophy (respectively 0.66 and 0.68). In our cohort, MRI parameters seem to be more predictive than clinical variables, which had a hazard ratio very close to 1. It is suggested that multimodal SC MRI could be a useful tool in survival prediction especially if used at the beginning of the disease and when combined with clinical variables. To validate it as a biomarker, confirmation of the results in bigger independent cohorts of patients is warranted. |
Author | Querin, G. Pradat, P.‐F. Delphine, S. El Mendili, M. M. Lenglet, T. Marchand‐Pauvert, V. Benali, H. |
Author_xml | – sequence: 1 givenname: G. orcidid: 0000-0001-6938-6368 surname: Querin fullname: Querin, G. organization: UPMC Univ Paris 06 – sequence: 2 givenname: M. M. surname: El Mendili fullname: El Mendili, M. M. organization: Icahn School of Medicine – sequence: 3 givenname: T. surname: Lenglet fullname: Lenglet, T. organization: Hôpital Pitié‐Salpêtrière – sequence: 4 givenname: S. surname: Delphine fullname: Delphine, S. organization: Institut Du Cerveau Et De La Moelle Épinière ‐ IHU‐A‐ICM – sequence: 5 givenname: V. surname: Marchand‐Pauvert fullname: Marchand‐Pauvert, V. organization: UPMC Univ Paris 06 – sequence: 6 givenname: H. surname: Benali fullname: Benali, H. organization: UPMC Univ Paris 06 – sequence: 7 givenname: P.‐F. surname: Pradat fullname: Pradat, P.‐F. email: pierre-francois.pradat@aphp.fr organization: Hôpital Pitié‐Salpêtrière Paris |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/28586096$$D View this record in MEDLINE/PubMed https://hal.sorbonne-universite.fr/hal-01540346$$DView record in HAL |
BookMark | eNp1kc1u1DAQxy1URD_gwAugSFzgkNbjryTHqloo0goOwNnyOpPWlWMHO9lqbzwCz8iT4GVLkZDwZcaj3_w94_8pOQoxICEvgZ5DORcY8Bw4Z90TcgJCtXW5wFHJuYRaAoVjcprzHaWUNYw-I8esla2inToh6fPkgvGVjamvxsXP7uf3H5NJZsQ5OVuN5ibgXJKEOQYTLFau1Fy4qYaYqrykrduW_ilh7-zsYqhcqMy4i3OK021p9GbGVIhsPaaYXX5Ong7GZ3zxEM_I13erL1fX9frT-w9Xl-vairbt6gFFj3xgQkoBSFsmO2aHxlAlwWBnhTJWqV5RpaRlmw1yFBxww1s0zQANPyNvD7q3xusplbHTTkfj9PXlWu9rFKSgXKgtFPbNgZ1S_LZgnvXoskXvTcC4ZA0dVUIp4Kygr_9B7-KSyh_uKWhbykSj_j5uy8454fA4AVC9N00X0_Rv0wr76kFx2YzYP5J_XCrAxQG4dx53_1fSq4-rg-QvmsikCQ |
CitedBy_id | crossref_primary_10_1080_14737175_2020_1715798 crossref_primary_10_1136_jnnp_2017_317214 crossref_primary_10_1111_risa_14128 crossref_primary_10_1111_ene_16268 crossref_primary_10_1016_j_nicl_2019_101984 crossref_primary_10_1038_s41598_023_47935_7 crossref_primary_10_1038_s41598_020_70125_8 crossref_primary_10_1002_mp_15936 crossref_primary_10_3389_fneur_2018_00844 crossref_primary_10_1016_j_nicl_2018_101618 crossref_primary_10_1002_nbm_3801 crossref_primary_10_1002_ana_25706 crossref_primary_10_1080_21678421_2017_1407795 crossref_primary_10_1016_S1474_4422_21_00465_8 crossref_primary_10_1097_WCO_0000000000000569 crossref_primary_10_3389_fneur_2019_00350 crossref_primary_10_1002_ana_25520 crossref_primary_10_1016_j_nmd_2019_07_008 crossref_primary_10_1002_acn3_51712 crossref_primary_10_17826_cumj_1228302 crossref_primary_10_1007_s00234_023_03191_0 crossref_primary_10_1016_j_cnp_2023_12_003 crossref_primary_10_1111_ene_13846 crossref_primary_10_1080_14737175_2018_1463160 crossref_primary_10_1292_jvms_21_0370 crossref_primary_10_1186_s40035_021_00255_0 crossref_primary_10_1016_j_nicl_2022_103199 crossref_primary_10_3389_fneur_2019_00229 crossref_primary_10_1038_s41598_018_19938_2 crossref_primary_10_1038_s41596_021_00588_0 crossref_primary_10_1007_s00415_020_10181_2 crossref_primary_10_1007_s00415_023_11727_w crossref_primary_10_1093_braincomms_fcab143 crossref_primary_10_3389_fneur_2018_01065 crossref_primary_10_1053_j_sult_2023_03_016 crossref_primary_10_1097_WCO_0000000000001169 crossref_primary_10_1016_j_jacr_2020_01_042 crossref_primary_10_1016_j_neures_2017_11_005 |
Cites_doi | 10.3109/21678421.2014.903974 10.1136/jnnp-2015-310998 10.3109/21678421.2013.852589 10.3109/17482960802566824 10.1002/mus.23720 10.1136/jnnp.2008.154252 10.1038/nrn3430 10.1016/S0022-510X(99)00210-5 10.1007/s007020050088 10.1002/jmri.24571 10.3109/17482968.2012.701308 10.1371/journal.pone.0095516 10.1371/journal.pone.0152439 10.1016/j.nicl.2016.10.008 10.1016/j.neuroimage.2010.11.089 10.1038/nrneurol.2014.184 10.1186/s12883-016-0672-6 10.1038/nrneurol.2013.153 10.1212/01.WNL.0000095961.66830.03 10.1136/jnnp.2006.100032 10.1016/j.neuroimage.2010.06.060 10.1159/000341316 10.3109/21678421.2013.844168 10.1080/14737159.2016.1199277 10.1007/s13311-016-0484-9 10.1001/archneurpsyc.1953.02320260029002 |
ContentType | Journal Article |
Copyright | 2017 EAN 2017 EAN. 2017 European Federation of Neurological Societies Distributed under a Creative Commons Attribution 4.0 International License |
Copyright_xml | – notice: 2017 EAN – notice: 2017 EAN. – notice: 2017 European Federation of Neurological Societies – notice: Distributed under a Creative Commons Attribution 4.0 International License |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TK 7U7 C1K K9. 7X8 1XC VOOES |
DOI | 10.1111/ene.13329 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Neurosciences Abstracts Toxicology Abstracts Environmental Sciences and Pollution Management ProQuest Health & Medical Complete (Alumni) MEDLINE - Academic Hyper Article en Ligne (HAL) Hyper Article en Ligne (HAL) (Open Access) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Health & Medical Complete (Alumni) Toxicology Abstracts Neurosciences Abstracts Environmental Sciences and Pollution Management MEDLINE - Academic |
DatabaseTitleList | CrossRef MEDLINE - Academic ProQuest Health & Medical Complete (Alumni) MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1468-1331 |
EndPage | 1046 |
ExternalDocumentID | oai_HAL_hal_01540346v1 10_1111_ene_13329 28586096 ENE13329 |
Genre | article Research Support, Non-U.S. Gov't Journal Article |
GrantInformation_xml | – fundername: Investissements d'Avenir funderid: ANR‐10‐IAIHU‐06 – fundername: Institut pour la Recherche sur la Moelle épinière et l'Encéphale (IRME) – fundername: Association Française contre les Myopathies‐Téléthon (AFM‐Téléthon) |
GroupedDBID | --- .3N .GA .Y3 05W 0R~ 10A 169 1OB 1OC 24P 29G 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5VS 66C 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8FI 8FJ 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAXRX AAZKR ABCQN ABCUV ABEML ABIVO ABJNI ABPVW ABUWG ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXQS ADBBV ADBTR ADEOM ADIZJ ADKYN ADMGS ADOZA ADPDF ADXAS ADZMN ADZOD AEEZP AEIGN AEIMD AENEX AEQDE AEUQT AEUYR AFBPY AFEBI AFGKR AFKRA AFPWT AFRAH AFZJQ AHMBA AIACR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BENPR BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CAG CCPQU COF CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBS EJD EMOBN ESX EX3 F00 F5P FEDTE FUBAC FYBCS FYUFA G-S G.N GODZA H.X HF~ HMCUK HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD OVEED P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 R.K RIG RIWAO RJQFR ROL RPM RX1 SAMSI SUPJJ TEORI UB1 UKHRP W8V W99 WBKPD WHWMO WIH WIJ WIK WOHZO WOW WQJ WVDHM WXI WXSBR XG1 YFH ZZTAW ~IA ~WT CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TK 7U7 C1K K9. 7X8 1XC VOOES |
ID | FETCH-LOGICAL-c4889-fe4de3f245541e082592cf7a0651ae9c46ac66d60665c2bbe3e431eb38ea7f173 |
IEDL.DBID | DR2 |
ISSN | 1351-5101 |
IngestDate | Fri Sep 06 12:36:29 EDT 2024 Fri Aug 16 09:44:15 EDT 2024 Sat Aug 31 00:00:05 EDT 2024 Fri Aug 23 03:00:03 EDT 2024 Sat Sep 28 08:49:00 EDT 2024 Sat Aug 24 01:18:05 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | spinal cord MRI spinal cord atrophy survival prediction motor neuron degeneration amyotrophic lateral sclerosis biomarkers |
Language | English |
License | 2017 EAN. Distributed under a Creative Commons Attribution 4.0 International License: http://creativecommons.org/licenses/by/4.0 |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4889-fe4de3f245541e082592cf7a0651ae9c46ac66d60665c2bbe3e431eb38ea7f173 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
ORCID | 0000-0001-6938-6368 |
OpenAccessLink | https://hal.sorbonne-universite.fr/hal-01540346 |
PMID | 28586096 |
PQID | 1918802476 |
PQPubID | 1066358 |
PageCount | 7 |
ParticipantIDs | hal_primary_oai_HAL_hal_01540346v1 proquest_miscellaneous_1906466132 proquest_journals_1918802476 crossref_primary_10_1111_ene_13329 pubmed_primary_28586096 wiley_primary_10_1111_ene_13329_ENE13329 |
PublicationCentury | 2000 |
PublicationDate | August 2017 |
PublicationDateYYYYMMDD | 2017-08-01 |
PublicationDate_xml | – month: 08 year: 2017 text: August 2017 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: Oxford |
PublicationTitle | European journal of neurology |
PublicationTitleAlternate | Eur J Neurol |
PublicationYear | 2017 |
Publisher | John Wiley & Sons, Inc Wiley |
Publisher_xml | – name: John Wiley & Sons, Inc – name: Wiley |
References | 2010; 53 2014; 5 2013; 14 2013; 47 2009; 10 1994; 169 2009; 80 2017; 14 2013; 12 2015; 41 2016; 87 2014; 15 2011; 55 1998; 105 2003; 61 1953; 69 2016; 16 2007; 78 2014; 22 2016; 13 2014; 10 2013; 9 2016; 11 e_1_2_7_6_1 e_1_2_7_5_1 e_1_2_7_4_1 e_1_2_7_3_1 e_1_2_7_9_1 e_1_2_7_8_1 e_1_2_7_7_1 e_1_2_7_19_1 e_1_2_7_18_1 e_1_2_7_16_1 e_1_2_7_2_1 e_1_2_7_15_1 e_1_2_7_14_1 e_1_2_7_13_1 e_1_2_7_12_1 e_1_2_7_11_1 e_1_2_7_10_1 e_1_2_7_26_1 e_1_2_7_27_1 e_1_2_7_28_1 Cedarbaum JM (e_1_2_7_17_1) 1994; 169 e_1_2_7_25_1 e_1_2_7_24_1 e_1_2_7_23_1 e_1_2_7_22_1 e_1_2_7_21_1 e_1_2_7_20_1 |
References_xml | – volume: 9 start-page: 513 year: 2013 end-page: 524 article-title: 25 years of neuroimaging in amyotrophic lateral sclerosis publication-title: Nat Rev Neurol – volume: 14 start-page: 11 year: 2017 end-page: 23 article-title: Neuroimaging endpoints in amyotrophic lateral sclerosis publication-title: Neurotherapeutics – volume: 69 start-page: 171 year: 1953 end-page: 92 article-title: Amyotrophic lateral sclerosis. A clinicoanatomic study of 53 cases publication-title: Arch Neurol Psychiatr – volume: 105 start-page: 689 year: 1998 end-page: 701 article-title: Evaluation of neuronal loss, astrocytosis and abnormalities of cytoskeletal components of large motor neurons in the human anterior horn in aging publication-title: J Neural Transm – volume: 53 start-page: 576 year: 2010 end-page: 583 article-title: Diffusion tensor imaging reveals regional differences in the cervical spinal cord in amyotrophic lateral sclerosis publication-title: NeuroImage – volume: 22 start-page: e95516 year: 2014 article-title: Multi‐parametric spinal cord MRI as potential progression marker in amyotrophic lateral sclerosis publication-title: PLoS One – volume: 10 start-page: 661 year: 2014 end-page: 670 article-title: The phenotypic variability of amyotrophic lateral sclerosis publication-title: Nat Rev Neurol – volume: 10 start-page: 310 year: 2009 end-page: 232 article-title: Prognostic factors in ALS: a critical review publication-title: Amyotroph Lateral Scler – volume: 13 start-page: 361 year: 2016 end-page: 369 article-title: Deep learning predictions of survival based on MRI in amyotrophic lateral sclerosis publication-title: Neuroimage Clin – volume: 14 start-page: 30 year: 2013 end-page: 38 article-title: Involvement of spinal sensory pathway in ALS and specificity of cord atrophy to lower motor neuron degeneration publication-title: Amyotroph Lateral Scler Frontotemporal Degener – volume: 47 start-page: 760 year: 2013 end-page: 2 article-title: 7‐T MRI of the spinal cord can detect lateral corticospinal tract abnormality in amyotrophic lateral sclerosis publication-title: Muscle Nerve – volume: 22 start-page: e95516 year: 2014 article-title: Fast and accurate semi‐automated segmentation method of spinal cord MR images at 3T applied to the construction of a cervical spinal cord template publication-title: PLoS One – volume: 16 start-page: 155 year: 2016 article-title: The value of magnetic resonance imaging as a biomarker for amyotrophic lateral sclerosis: a systematic review publication-title: BMC Neurol – volume: 5 start-page: 93 year: 2014 end-page: 97 article-title: Spinal cord atrophy correlates with disease duration and severity in amyotrophic lateral sclerosis publication-title: Amyotroph Lateral Scler Frontotemporal Degener – volume: 11 start-page: e0152439 year: 2016 article-title: Cervical spinal cord atrophy profile in adult SMN1‐linked SMA publication-title: PLoS One – volume: 169 start-page: 13 year: 1994 end-page: 21 article-title: The ALSFRS‐R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III) publication-title: J Neurol Sci – volume: 78 start-page: 480 year: 2007 end-page: 484 article-title: Diffusion anisotropy of the cervical cord is strictly associated with disability in amyotrophic lateral sclerosis publication-title: J Neurol Neurosurg Psychiatry – volume: 15 start-page: 84 year: 2014 end-page: 92 article-title: Multimodal tract‐based analysis in ALS patients at 7T: a specific white matter profile? publication-title: Amyotroph Lateral Scler Frontotemporal Degener – volume: 14 start-page: 248 year: 2013 end-page: 264 article-title: The changing scene of amyotrophic lateral sclerosis publication-title: Nat Rev Neurosci – volume: 87 start-page: 628 year: 2016 end-page: 632 article-title: Rate of disease progression: a prognostic biomarker in ALS publication-title: J Neurol Neurosurg Psychiatry – volume: 80 start-page: 53 year: 2009 end-page: 55 article-title: A longitudinal diffusion tensor MRI study of the cervical cord and brain in amyotrophic lateral sclerosis patients publication-title: J Neurol Neurosurg Psychiatry – volume: 61 start-page: 1503 year: 2003 end-page: 1507 article-title: A comparison of muscle strength testing techniques in amyotrophic lateral sclerosis publication-title: Neurology – volume: 16 start-page: 853 year: 2016 end-page: 68 article-title: Further development of biomarkers in amyotrophic lateral sclerosis publication-title: Expert Rev Mol Diagn – volume: 41 start-page: 454 year: 2015 end-page: 9 article-title: Validation of a semiautomated spinal cord segmentation method publication-title: J Magn Reson Imaging – volume: 55 start-page: 1024 year: 2011 end-page: 1033 article-title: Demyelination and degeneration in the injured human spinal cord detected with diffusion and magnetization transfer MRI publication-title: NeuroImage – volume: 12 start-page: 81 year: 2013 end-page: 90 article-title: Predicting survival of patients with amyotrophic lateral sclerosis at presentation: a 15‐year experience publication-title: Neurodegener Dis – volume: 15 start-page: 453 year: 2014 end-page: 456 article-title: Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis publication-title: Amyotroph Lateral Scler Frontotemporal Degener – ident: e_1_2_7_4_1 doi: 10.3109/21678421.2014.903974 – ident: e_1_2_7_5_1 doi: 10.1136/jnnp-2015-310998 – ident: e_1_2_7_15_1 doi: 10.3109/21678421.2013.852589 – ident: e_1_2_7_7_1 doi: 10.3109/17482960802566824 – ident: e_1_2_7_12_1 doi: 10.1002/mus.23720 – ident: e_1_2_7_9_1 doi: 10.1136/jnnp.2008.154252 – ident: e_1_2_7_2_1 doi: 10.1038/nrn3430 – volume: 169 start-page: 13 year: 1994 ident: e_1_2_7_17_1 article-title: The ALSFRS‐R: a revised ALS functional rating scale that incorporates assessments of respiratory function. BDNF ALS Study Group (Phase III) publication-title: J Neurol Sci doi: 10.1016/S0022-510X(99)00210-5 contributor: fullname: Cedarbaum JM – ident: e_1_2_7_23_1 doi: 10.1007/s007020050088 – ident: e_1_2_7_19_1 doi: 10.1002/jmri.24571 – ident: e_1_2_7_11_1 doi: 10.3109/17482968.2012.701308 – ident: e_1_2_7_10_1 doi: 10.1371/journal.pone.0095516 – ident: e_1_2_7_20_1 doi: 10.1371/journal.pone.0152439 – ident: e_1_2_7_27_1 doi: 10.1016/j.nicl.2016.10.008 – ident: e_1_2_7_21_1 doi: 10.1016/j.neuroimage.2010.11.089 – ident: e_1_2_7_3_1 doi: 10.1038/nrneurol.2014.184 – ident: e_1_2_7_28_1 doi: 10.1186/s12883-016-0672-6 – ident: e_1_2_7_8_1 doi: 10.1038/nrneurol.2013.153 – ident: e_1_2_7_16_1 doi: 10.1371/journal.pone.0095516 – ident: e_1_2_7_18_1 doi: 10.1212/01.WNL.0000095961.66830.03 – ident: e_1_2_7_14_1 doi: 10.1136/jnnp.2006.100032 – ident: e_1_2_7_13_1 doi: 10.1016/j.neuroimage.2010.06.060 – ident: e_1_2_7_6_1 doi: 10.1159/000341316 – ident: e_1_2_7_24_1 doi: 10.3109/21678421.2013.844168 – ident: e_1_2_7_25_1 doi: 10.1080/14737159.2016.1199277 – ident: e_1_2_7_26_1 doi: 10.1007/s13311-016-0484-9 – ident: e_1_2_7_22_1 doi: 10.1001/archneurpsyc.1953.02320260029002 |
SSID | ssj0002720 |
Score | 2.4305656 |
Snippet | Background and purpose
Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the... Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the assessment of disease... Background and purpose Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis ( ALS ). Neuroimaging seems to be promising in the... Background and purpose Assessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the... BACKGROUND AND PURPOSEAssessing survival is a critical issue in patients with amyotrophic lateral sclerosis (ALS). Neuroimaging seems to be promising in the... Background: Assessing survival is a critical issue in patients with Amyotrophic Lateral Sclerosis (ALS). Neuroimaging seems to be promising in the assessment... |
SourceID | hal proquest crossref pubmed wiley |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 1040 |
SubjectTerms | Adult Aged Amyotrophic lateral sclerosis Amyotrophic Lateral Sclerosis - diagnostic imaging Amyotrophic Lateral Sclerosis - mortality Amyotrophic Lateral Sclerosis - pathology Anisotropy Atrophy Bioengineering Biomarkers Cross-Sectional Studies Diffusion Tensor Imaging - methods Disease Progression Female Humans Imaging Life Sciences Magnetic resonance imaging Magnetic Resonance Imaging - methods Male Mathematical models Medical imaging Middle Aged motor neuron degeneration Multimodal Imaging Neuroimaging Neurology Neurons and Cognition NMR Nuclear magnetic resonance Patients Predictions Prognosis Resonance Spinal cord Spinal Cord - diagnostic imaging Spinal Cord - pathology spinal cord atrophy spinal cord MRI Survival survival prediction Survival Rate Vertebrae |
Title | Spinal cord multi‐parametric magnetic resonance imaging for survival prediction in amyotrophic lateral sclerosis |
URI | https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fene.13329 https://www.ncbi.nlm.nih.gov/pubmed/28586096 https://www.proquest.com/docview/1918802476/abstract/ https://search.proquest.com/docview/1906466132 https://hal.sorbonne-universite.fr/hal-01540346 |
Volume | 24 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB5RDqgXXn0QXnJRD1yyIo6TbNQTQotWCDiUInFAimyvXVawyWqziwQnfgK_kV_SGedRKEJCPUTKw3nZM5Pvi8efAb5rqzQJTPoYHLkvEqX8lNNmwK21A25S5RJkT-P-uTi6iC7m4EczFqbSh2h_uJFnuHhNDi5V-czJMRR0kGBxGrxHQnoEiH7-lY6i_kVHtqLAJ7urVYUoi6c988W36MMVZUK-hpkvUav77BwuwWXzwFW2yXVnNlUdff-PluN_vtEyLNZwlO1X9rMCcyZfhYWTusP9E0zOxjRtFiOOylzy4dPDI8mFj2gmLs1G8ndOwyAZsvaCtDsMG47cxEcM0TArZxiJ0JbZeEKXJCNgw5zJ0V0xnRTjKzzxRtIY6BtW4v2xloblZzg_7P066Pv1NA2-FpQjZY0YmNBygcgkMEQ5U65tIhHcBNKkWsRSx_GAmFKkuVImNIhakMR3jUxskIRfYD4vcrMGzCqThLHQaWRSsSe7SqskMkj-cRmEqfJgp2mwbFypcWQNi8Hay1ztYSFsyvY46Wf3948z2keAcS8U8W3gwWbT0lnttWWG3BXDGRdJ7MG39jD6G3WiyNwUMyqDIA5BTcg9-FpZSHsr3o26MXJCD3ZdO7_9jFnvtOdW1t9fdAM-csIULvtwE-ank5nZQkQ0VdvO9P8AwMAItg |
link.rule.ids | 230,315,786,790,891,1382,27957,27958,46329,46753 |
linkProvider | Wiley-Blackwell |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LT9wwEB7xkCiXFmihaSkYxKGXrIjjJBupF1QtWmDZAw-JSxXZXrusyiarfVRqT_0J_Y38EmacR6FVpaqHSHk4L3tm8n3x-DPAgbZKk8Ckj8GR-yJRyk85bQbcWjvgJlUuQbYfd6_F6U10swAf6rEwpT5E88ONPMPFa3Jw-iH9yMsxFrSQYfF0EZbR3SNHqC5-iUdRD6OjW1Hgk-VVukKUx9Oc-uRrtHhLuZB_As2nuNV9eI5fwKf6kct8ky-t-Uy19Pff1Bz_953W4HmFSNlRaULrsGDyDVg5r_rcX8LkckwzZzGiqczlH97_-EmK4SOajEuzkfyc00hIhsS9IPkOw4YjN_cRQ0DMpnMMRmjObDyhS5IdsGHO5OhbMZsU41s88U7SMOg7NsX7YzUNp6_g-rhz9bHrVzM1-FpQmpQ1YmBCywWCk8AQ60y5tolEfBNIk2oRSx3HAyJLkeZKmdAgcEEe3zYysUESbsJSXuTmNTCrTBLGQqeRScWhbCutksgg_8dlEKbKg_26xbJxKciR1UQGay9ztYeFsC2b4ySh3T3qZbSPMONhKOKvgQfbdVNnleNOM6SvGNG4SGIP9prD6HLUjyJzU8ypDOI4xDUh92CrNJHmVrwdtWOkhR68dw3992fMOv2OW3nz70V34Vn36ryX9U76Z29hlRPEcMmI27A0m8zNOwRIM7Xj_OABScYM2A |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9QwEB61Raq4lHcJFDCIA5esGsdxNuJUwa4WKCsEVOoBKbIdm67aTaJ9VConfgK_kV_CjPOAgpAQhyjZxNkk9szk--LxZ4CnxmlDApMhBkceilTrMOP0M-LOuYLbTPsE2amcHInXx8nxBjzvxsI0-hD9BzfyDB-vycHrwv3i5BgKBkiweLYJV4TENSGi9z-1o6iD0bOtJArJ8FpZIUrj6U-99DLaPKFUyD9x5mXY6t8742vwqbvjJt3kdLBe6YH58puY438-0nXYafEoO2gM6AZs2PImbL9te9xvweJDTfNmMSKpzGcffv_6jfTC5zQVl2Fz9bmkcZAMaXtF4h2WzeZ-5iOGcJgt1xiK0JhZvaC_JCtgs5Kp-UW1WlT1CZ54pmgQ9Blb4vWxlmbL23A0Hn18MQnbeRpCIyhJyllR2NhxgdAkssQ5M25cqhDdRMpmRkhlpCyIKiWGa21ji7AFWfzQqtRFaXwHtsqqtHeBOW3TWAqTJTYT-2qojU4Ti-wflyLOdABPugbL60aOI-9oDNZe7msPC2FT9sdJQHtycJjTPkKM-7GQ51EAe11L563bLnMkrxjPuEhlAI_7w-hw1IuiSlutqQyiOEQ1MQ9gt7GQ_lJ8mAwlksIAnvl2_vs95qPpyG_c-_eij2D73ctxfvhq-uY-XOWEL3wm4h5srRZr-wDR0Uo_9F7wAyUMC4c |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Spinal+cord+multi%E2%80%90parametric+magnetic+resonance+imaging+for+survival+prediction+in+amyotrophic+lateral+sclerosis&rft.jtitle=European+journal+of+neurology&rft.au=Querin%2C+G.&rft.au=El+Mendili%2C+M.+M.&rft.au=Lenglet%2C+T.&rft.au=Delphine%2C+S.&rft.date=2017-08-01&rft.issn=1351-5101&rft.eissn=1468-1331&rft.volume=24&rft.issue=8&rft.spage=1040&rft.epage=1046&rft_id=info:doi/10.1111%2Fene.13329&rft.externalDBID=10.1111%252Fene.13329&rft.externalDocID=ENE13329 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1351-5101&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1351-5101&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1351-5101&client=summon |